Summary
Signal counts
Assets tracked: 3
Watchlist assets: 2
Registry stop assets: 0
Sponsor overview
Roswell Park Cancer Institute
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT05651594 | https://clinicaltrials.gov/study/NCT01902173 | https://clinicaltrials.gov/study/NCT05775471 | https://clinicaltrials.gov/study/NCT01529827 | https://clinicaltrials.gov/study/NCT00281736
Assets
Linked programs
- Biopsy: Watchlist Signal (2/5)
- fludarabine phosphate: Low Signal (1/5)
- HPPH: Results Not Found Signal (2/5)